nice glp 1 guidelines NG28: New for Type 2 Diabetes Treatment | Paramesh Shamanna posted on the topic Nutritional priorities to support GLP-1

As people age, we see the musculoskeletal complications of excessive weight

Originally developed for type 2 diabetes, GLP-1 receptor agonists are now driving one of the fastest-growing pharmaceutical markets globally - with expanding applications in obesity management, cardiovascular health, and other chronic conditions

Some patients may experience mild nausea, especially at the beginning

The main manufacturing process utilizes our previously reported methods of micro-molding, 3D layer-by-layer assembly, and heat sintering [4143]

What's your sense about that

( see also R2G article: Are GLP-1 Apps the Breakthrough for Companion Solutions